Align Technology, Inc. (NASDAQ:ALGN) Q4 2023 Earnings Conference Call January 31, 2024 4:30 PM ET Company Participants Shirley Stacy - VP, Corporate Communications & IR Joseph Hogan - President, CEO & Director John Morici - CFO & EVP, Global Finance Conference Call Participants Elizabeth Anderson - Evercore ISI Jeffrey Johnson - Robert W. Baird & Co. Jonathan Block - Stifel, Nicolaus & Company Jason Bednar - Piper Sandler & Co. Brandon Vazquez - William Blair & Company Nathan Rich - Goldman Sachs Group Mich ...

For the quarter ended December 2023, Align Technology (ALGN) reported revenue of $956.73 million, up 6.1% over the same period last year. EPS came in at $2.42, compared to $1.73 in the year-ago quarter.The reported revenue represents a surprise of +3.03% over the Zacks Consensus Estimate of $928.57 million. With the consensus EPS estimate being $2.18, the EPS surprise was +11.01%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

Shares of Align Technology Inc. ALGN, +0.97% jumped 14.1% after hours on Wednesday after the company, best known for its Invisalign teeth-alignment system, forecast first-quarter and full-year sales that were above expectations. Align said it expected first-quarter sales of $960 million to $980 million, above the FactSet consensus forecast for $947 million. For the full year, the company expected sales to be “up mid-single digits” year over year, compared with FactSet expectations for around 4% growth. For ...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that for the first time, Align Technology is included in the Intellectual Property Owners Association annual report of the top 300 organizations granted U.S. patents. For 2023, Align is at position ...

Analysts on Wall Street project that Align Technology (ALGN) will announce quarterly earnings of $2.17 per share in its forthcoming report, representing an increase of 25.4% year over year. Revenues are projected to reach $928.43 million, increasing 3% from the same quarter last year.Over the last 30 days, there has been an upward revision of 1.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial for ...

Align Technology’s (ALGN) macroeconomic issues and currency headwinds continue to dent growth. The stock carries a Zacks Rank #4 (Sell).Align Technology is suffering from the ongoing industry-wide trend of staffing shortages and supply chain-related hazards. Deteriorating international trade, with global inflationary pressure leading to a tough situation related to raw material and labor costs, as well as freight charges and rising interest rates, all have put the dental treatment space (which is highly ele ...

Align Technology, Inc. (ALGN) is set to release fourth-quarter 2023 results on Jan 31 after the closing bell.The company posted adjusted earnings per share (EPS) of $2.14 in the last reported quarter, which missed the Zacks Consensus Estimate by 5.3%. Align Technology beat earnings estimates in three of the trailing four quarters and missed in one, the average negative surprise being 6.53%.Let’s look at how things have shaped up before this announcement.Factors at PlayClear Aligner BusinessDespite the diffi ...

Align Technologies (ALGN) is likely to grow in the coming quarters, backed by its impressive strategic alliances. Over the past couple of years, the company has successfully launched its first subscription-based clear aligner program, the Doctor Subscription Program (“DSP”), worldwide. A strong solvent balance sheet appears highly promising. However, the substantial dependence on the Invisalign system and currency fluctuations remain a concern for ALGN.In the past year, this Zacks Rank #3 (Hold) stock has i ...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2023 financial results on Wednesday, January 31, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be ...

Key PointsA newly dovish FED has opened the floodgates for budget increases across the economy, and this sector is starting the trend by adding jobs.More than adding jobs, the sector has added investor interest in stocks like Pfizer and, most specifically, in Align Technology.Analysts and markets are all over this stock, and even the CEO has bought up to $2 million in stock ahead of the next rally.5 stocks we like better than PfizerBecause the past few months in the stock market have been a wild emotional r ...